TransMedics Group, Inc. is a commercial stage medical technology company, which engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in October 2018 and is headquartered in Andover, MA.
Company profile
Ticker
TMDX
Exchange
Website
CEO
Waleed H. Hassanein
Employees
Incorporated
Location
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Integer • Masimo • Natus Medical • LivaNova • BioPlus Acquisition • QT Imaging • Outset Medical ...
Former names
Transmedics Inc
SEC CIK
Corporate docs
Latest filings (excl ownership)
D/A
$63.73M in equity, sold $63.73M, 20 investors
12 Jul 16
D
$51.23M in equity, sold $51.23M, 20 investors
26 May 16
D
$500K in equity / options, sold $500K, 1 investor
21 Sep 15
D
$20M in equity, sold $20M, 11 investors
4 Jun 15
D
$29.97M in equity
13 Jun 13
D
$36.15M in equity / options, sold $36.15M, 15 investors
21 Nov 12
D
$22.5M in equity, sold $5.92M, 9 investors
15 Aug 11
D
$35.41M in equity, sold $35.41M, 26 investors
1 Mar 10
D
$3.62M in debt, sold $3.57M, 13 investors
8 Dec 09
D
Exempt offering of security
15 Jul 09
Latest ownership filings
No filings
News
Top 3 Health Care Stocks That May Crash In May
24 May 24
10 Health Care Stocks Whale Activity In Today's Session
3 May 24
Canaccord Genuity Maintains Buy on TransMedics Gr, Raises Price Target to $117
1 May 24
Dow Jumps 200 Points Following Fed Decision; Pfizer Earnings Top Estimates
1 May 24
TD Cowen Maintains Buy on TransMedics Gr, Raises Price Target to $130
1 May 24